Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many households in Vietnam raise animals for food production, particularly chickens, using large amounts of antimicrobials with no veterinary support, and those antimicrobials find their way into the food chain. The ViParc project conducts intervention trials similar to human clinical trials, to help farmers reduce the level of antimicrobials used when raising chickens.

My name is Juan Carrique-Mas, I am based at Oxford University Clinical Research Unit in Ho Chi Minh City in Vietnam. I am currently funded by the Wellcome Trust to carry out a large-scale field intervention to help farmers in the Mekong Delta of Vietnam to reduce their reliance on antimicrobials to produce chickens.

Antimicrobial use and antimicrobial resistance is a considerable problem in animal production, not only in human medicine, and this has been realised only very recently. It is a big problem because farmers use a large amount of antimicrobials to raise the chicks and the chickens, because they basically have no technical support from the veterinary system. It is also a problem because most of these small-scale farms have virtually no bio-security, that is almost no separation between the farming space and the household space. That means that there is a lot of exposure in these communities to the animals they are raising. It’s been estimated that approximately half of the population across the country would raise some form of food animal that can be from a few chickens to several hundred chickens, pigs, ducks etc. Overall in terms of households the census speaks about between 8 and 10 million animal raising households.

Antimicrobial resistance is indeed what we call these days a one-health-issue; we cannot just look at humans or animals or the environment, everything is interconnected. In the case of antimicrobial use in animal production, it is quite clear that there can be transmission of resistant bacteria which are pathogenic to the humans causing disease in those humans through contact, but also indirectly through the consumption of food from these animals: contaminated meat, milk, eggs and so on. Furthermore those resistant bacteria can spread into the environment and contaminate water streams, rivers, crops, and end up in our food as well even though we are not directly raising those animals.

The ViParc Project stands for Vietnamese Platform for Antimicrobial Reductions in Chicken production. I also tell people that the ‘Vi’ stands for Veterinary Intervention because we are trialling an intervention system to help farmers reduce their levels of antimicrobials in raising their chickens. It is very much focused on small scale production systems, we are not looking at the industrial, integrated farms, which are still relatively few, but on the medium and the small scale farmer. What we are doing here is very much like a clinical trial in human medicine, where we have an observation phase and then we randomly allocate two interventions and one control. One novelty of the ViParc Project compared to the other research projects is that we have included a strong, socioeconomic component because we realise that farms are businesses. If we don’t consider them to be running their own business, if we just look at it from a health perspective only, we will not be able to have an impact on them.

What is really challenging about the Vietnamese Mekong Delta situation is that farms are much more complex than we envisaged. Every farmer does things in a slightly different way, and that presents problems because we cannot design an intervention that fits all. That’s why the intervention has to be tailor-made, every farmer will be approached and will be advised on the specific problems on their farms.

I believe that the type of research that I am currently conducting, which is an intervention trial, is very relevant and very necessary. There is a lack of intervention studies that look at the important issue of antimicrobial use and resistance in animal production. Most of their studies are observational, and very few of them attempt to do something at a large scale. But I also feel that my study, my intervention is quite representative of other production systems and even for other countries that conduct similar types of farming to Vietnam.

Juan Carrique-Mas

Dr Juan Carrique-Mas conducts the ViParc Project that helps farmers in the Mekong Delta to raise meat chickens using lower amounts of antimicrobials. He provides veterinary support, training courses on poultry diseases and poultry farm management, and helps them improve their productivity and reduce their reliance on antimicrobials.

More podcasts related to Global Health

Mike English: Health services that deliver for newborns

Basic hospital care may be key to saving newborn lives. Professor Mike English outlines a multidisciplinary project engaging policy-makers and practitioners in Kenya. This project demonstrated poor coverage of Nairobi’s 4.25 million population if a sick newborn baby needs quality hospital care. Using novel research approaches the team also identified how severe shortages of nurses contribute to poor quality of care for patients and negatively affect nurses themselves.

Tran Hien: Infectious diseases in the tropics

Although incidence of malaria has decreased in Vietnam, the burden of infectious diseases remains high and weighs heavily on the health care system. Clinical research aims to allow investments to go further: findings in the laboratory, tested in clinical trials and then applied to the community, help improve diagnosis and management.

Ronald Geskus: Sophisticated biostatistics for complex clinical research

The role of biostatisticians in clinical research is to contribute to trial design, by calculating sample size for example, and to help draw correct conclusions from the data, discriminating important information from noise. They are instrumental in the translation of a practical problem into a statistical model, and the translation of the result into practice.

Rogier Van Doorn: Research at OUCRU Hanoi

Antibiotics are widely used in Vietnam, leading to widespread antimicrobial resistance. Monitoring antibiotic use helps inform the government to change treatment guidelines and implement antibiotic stewardship programmes. This may also prevent the transmission of resistant bacteria outside the country.

Heiman Wertheim: Clinical research in low and middle-income countries

Drug resistant infections are a global crisis and we cannot focus on our own country only. Clinical trials in low and middle income countries where the burden is highest, as well as work with local communities and engagement with policy makers help influence public health policies.

Guy Thwaites: Tuberculosis meningitis

Tuberculosis meningitis affects a fractions of TB patients but causes high levels of mortality and morbidity. A recent trial at OUCRU showed that aspirin can greatly improve outcomes. Such trial is typical of the work done in our Vietnam units, where all the research is focussed on improving the outcome for patients directly.

Motiur Rahman: OUCRU laboratory management

OUCRU laboratories provide support to the unit’s extensive clinical research programme, from level 2 laboratory to SAPO 4 laboratory for high-risk pathogens responsible for zoonotic infections. Early diagnosis and detection of antimicrobial resistance helps prescribe the right medicine in time, contributing to better patient management.

Raph Hamers: Developing collaborative clinical trials in Indonesia

Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.

Jeremy Day: Central nervous system and HIV infections in Vietnam

Brain infections such as meningitis and encephalitis are highly debilitating diseases, and an accurate diagnostic is essential to give patients the best treatment available. For cryptococcal meningitis, clinical trials focus on prevention, for an early diagnosis, and novel ways to use existing treatments or repurpose old drugs.

Abhilasha Karkey: Connecting research with communities in Nepal

Antimicrobial resistance is a huge burden in Nepal, particularly in hospitals where many nosocomial infections are caused by resistant pathogens. With limited resources, little infection controls and proper guidelines in place, finding out the main risk factors helps reduce infection rates within a hospital and better target vaccination campaigns.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.